VAERS reports by lot

GSK DTaP/Tdap lot JF7DM: VAERS reports

21 VAERS reports list lot JF7DM as a GSK DTaP/Tdap vaccine, received between 2025-07-30 and 2026-04-24. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1050%
Allergic / Anaphylactic315%
General / Systemic (non-local)315%
Respiratory210%
Gastrointestinal15%
Psychiatric / Neuropsychiatric15%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan2
Massachusetts2
Alabama2
Arkansas2
California2
Pennsylvania2
Montana1
Kansas1
Virginia1
Georgia1
North Carolina1
Texas1

Reports by month received

MonthReportsBar
2025-071
2025-083
2025-094
2025-101
2025-113
2025-123
2026-011
2026-023
2026-031
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): HB7L7 · HF2YA · J947T · K4979 · K5F5R · L5229

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.